AAN’s New Painful Diabetic Polyneuropathy Guidelines

Doctors in a meeting.

A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. […]

Read More… from AAN’s New Painful Diabetic Polyneuropathy Guidelines

PNRR Study on Vitamin B6

PNRR

Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels […]

Read More… from PNRR Study on Vitamin B6

Peripheral Neuropathy is Again an Eligible Condition for DOD Grants

Capitol building

Last week, the Chairman of the Senate Committee on Appropriations released the Majority’s draft of the fiscal year 2022 (FY22) Defense Appropriations Act. The Foundation for Peripheral Neuropathy is pleased to see that this draft legislation once again includes “peripheral neuropathy” among the eligible conditions for grants in FY22 from the Department of Defense’s Peer […]

Read More… from Peripheral Neuropathy is Again an Eligible Condition for DOD Grants

Vitamins and Supplements for Nerve Health

Veggies in a pill.

Our friends at LivOn Labs, producer of vitamins and supplements, share information on supplements for nerve health with us. LivOn Labs is a supporter and partner of FPN. FPN recommends consulting with your health care provider before adding any supplements to your medical regime. Stop us if this sounds familiar. You read an article claiming […]

Read More… from Vitamins and Supplements for Nerve Health

Research Study Back on Track!

Imagine Study.

Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to […]

Read More… from Research Study Back on Track!